Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the ...

AbbVie is a sector mainstay that had no fewer than 12 drugs with net sales above $1 billion last year. It also paid a generous dividend. 10 stocks we like better than AbbVie › It isn't easy to find a ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is slated to report third-quarter 2025 results on Nov. 5, before the opening bell.

As of Wednesday, December 31, Vanda Pharmaceuticals Inc.’s VNDA share price has surged by 34.23%, which has investors questioning if this is right time to sell.

Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts.

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to beat earnings when it reports second-quarter 2025 results on Aug. 5 ...

AbbVie is a sector mainstay that had no fewer than 12 drugs with net sales above $1 billion last year. It also paid a generous dividend. Some pharmaceutical companies dream of developing and launching ...